The aim of this clinical study is to optimize treatment outcomes in patients with mixed forms of urinary incontinence by implanting an adjustable suburethral sling and to determine factors influencing treatment effectiveness. The main questions it aims to answer are:
1. What is the effectiveness of an adjustable suburethral sling in patients with mixed urinary incontinence? 2. How do preoperative medications and other factors affect the effectiveness of adjustable suburethral sling implantation? 3. How does quality of life change in these patients after surgery? Participants will undergo implantation of an adjustable suburethral sling. Postoperatively, the effectiveness of the sling for mixed urinary incontinence will be assessed. Predictors of treatment effectiveness will also be identified.
Patients will be examined 24 hours after surgery, 2 months later, and 1 year later.
Women over 18 years of age.
Mixed urinary incontinence (stress and urgency components, with the stress component being predominant or equal) of moderate to severe severity, confirmed by questionnaire data.
Signed informed consent to participate in the study.
Isolated stress or urge urinary incontinence.
Contraindications to diagnosis and treatment.
Obstructive urination, large residual urine volume.
Chronic pelvic pain syndrome.
Single group
implantation of an adjustable suburethral sling
Procedure/SurgerySurgical access will be achieved through the anterior vaginal wall, projecting toward the middle third of the urethra. The UroSling endoprosthesis will be inserted using the standard technique.
The Overactive Bladder Symptom Score (OABSS) questionnaire
Changes in scores on the Overactive Bladder Symptom Score (OABSS) questionnaire at 24 hours postoperatively compared to pre-treatment values.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
